Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
Clinical trial NCT05210803 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05210803
- Sponsor
- AbbVie
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-20
- Primary completion
- 2031-07-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.